[Role of cyclooxygenase-2 in inhibition of human gastric adenocarcinoma cell line SGC-7901 by c9, t11-conjugated linoleic acid]

Wei Sheng Yan Jiu. 2005 May;34(3):333-5.
[Article in Chinese]

Abstract

Objective: To study the effects of c9, t11-conjugated linoleic acid (c9, t11-CLA) on the critical enzyme (COX-2) and its product - prostaglandin E2 (PGE2) of linoleic acid metabolism path in human gastric adenocarcinoma cell line (SGC-7901).

Methods: Expression of COX-2 mRNA and protein were measured by reverse transcription polymerase chain reaction (RT-PCR) and Western blot, PGE2 was determined by radioimmunoassay (RIA).

Results: At the concentrations of 25, 50, 100, 200 pmol/L, c9, t11-CLA suppressed the expression of COX-2 mRNA, protein and PGE.

Conclusion: COX-2 is involved anti-cancer action of c9, t11-CLA and is likely to act as an important target.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / enzymology
  • Adenocarcinoma / pathology
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism*
  • Cyclooxygenase 2 Inhibitors / pharmacology*
  • Dinoprostone / metabolism
  • Humans
  • Linoleic Acid / pharmacology
  • Linoleic Acids, Conjugated / pharmacology*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Stomach Neoplasms / enzymology
  • Stomach Neoplasms / pathology*

Substances

  • Cyclooxygenase 2 Inhibitors
  • Linoleic Acids, Conjugated
  • RNA, Messenger
  • 9,11-linoleic acid
  • Linoleic Acid
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Dinoprostone